McGladrey, Margaret
Goetz, Michael
Nakayima, Julie
Booty, Marisa
Berkshire, Ashley
Funding for this research was provided by:
National Institute on Drug Abuse (UM1DA049406)
National Institute on Drug Abuse (UM1DA049406)
National Institute on Drug Abuse (UM1DA049406)
National Institute on Drug Abuse (UM1DA049406)
National Institute on Drug Abuse (UM1DA049406)
Article History
Received: 14 April 2026
Accepted: 6 July 2026
First Online: 8 July 2026
Declarations
:
: The following statement on ethics approval and consent including the name of the ethics committee that approved the study and the committee’s reference number is on page 4: “In accordance with the Common Rule (45 CFR 46), the protocol (Pro00038088) was approved by Advarra Inc., HCS’s single Institutional Review Board, and was granted an addendum for HCS-KY to receive additional data from VOH for jails participating in sustainment in both the Wave 1 and Wave 2 communities.”
: Not applicable.
: The authors declare no competing interests.